Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
RESEARCH TOOLSreports
MoonLake Immunotherapeutics (MLTX) Ownership - Who Owns MoonLake Immunotherapeutics?
288 Followers
MoonLake Immunotherapeutics (MLTX) Ownership Overview
63.42% Insiders
14.34% Mutual Funds
0.45% Other Institutional Investors
21.80% Public Companies and
Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail and individual investors. Approximately 14.79% of the company’s stock is owned by Institutional Investors, 63.42% is owned by Insiders and 21.80% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 10, 2023 | Bihua Chen >10% Owner | Bought | $3523868 |
| Oct 04, 2023 | Bihua Chen >10% Owner | Bought | $16799445 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $43298 | |
| Mar 31, 2024 | Bought | $4395125 | |
| Mar 31, 2024 | Bought | $10418455 | |
| Mar 31, 2024 | Bought | $17028572 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,051,348 | Institution | 1.67% | 44,188,156 | |
| 1,026,276 | Institution | 1.63% | 43,134,380 | |
| 939,306 | Institution | 1.49% | 39,479,031 | |
| 718,650 | Institution | 1.14% | 30,204,860 | |
| 548,604 | Institution | 0.87% | 23,057,826 | |
| 522,634 | Institution | 0.83% | 21,966,307 | |
| 421,422 | Institution | 0.67% | 17,712,367 | |
| 409,599 | Institution | 0.65% | 17,215,446 | |
| 388,307 | Institution | 0.62% | 16,320,543 | |
| 339,012 | Institution | 0.54% | 14,248,674 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,051,348 | Institution | 1.67% | 44,188,156 | |
| 1,026,276 | Institution | 1.63% | 43,134,380 | |
| 939,306 | Institution | 1.49% | 39,479,031 | |
| 718,650 | Institution | 1.14% | 30,204,860 | |
| 548,604 | Institution | 0.87% | 23,057,826 | |
| 522,634 | Institution | 0.83% | 21,966,307 | |
| 421,422 | Institution | 0.67% | 17,712,367 | |
| 409,599 | Institution | 0.65% | 17,215,446 | |
| 388,307 | Institution | 0.62% | 16,320,543 | |
| 332,441 | Institution | 0.53% | 13,972,495 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 52,950 | Institution | 0.08% | 2,152,947 | |
| 49,042 | Institution | 0.08% | 2,069,572 | |
| 17,284 | Institution | 0.03% | 957,857 | |
| 21,511 | Institution | 0.03% | 907,764 | |
| 20,062 | Institution | 0.03% | 846,616 | |
| 18,693 | Institution | 0.03% | 760,057 | |
| 16,730 | Institution | 0.03% | 671,710 | |
| 11,431 | Institution | 0.02% | 464,784 | |
| 10,795 | Institution | 0.02% | 438,925 | |
| 7,780 | Institution | 0.01% | 312,367 |
FAQ
Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 0.45% of the company's stock is held by institutional investors, 63.42% is held by insiders, and 21.80% is held by retail investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.45% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.80% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
T. ROWE PRICE HEALTH SCIENCES FUND, INC. owns the most shares of MoonLake Immunotherapeutics (MLTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.